 |
市場調查報告書
商品編碼
1550577
全球支氣管炎治療市場：按類型、按治療方法、按藥物類別、按給藥途徑、按分銷管道、按地區Global Bronchitis Treatment Market, By Type, By Treatment, By Drug Class, By Route of Administration, By Distribution Channel, By Geography |
||||||
預計2024年全球支氣管炎治療市場規模將達82.2億美元，2024年至2031年複合年成長率為5.3%，2031年將達118.1億美元。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 82.2億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024-2031 |
| 預測 2024-2031 年複合年成長率： | 5.30% | 2031 年金額預測 | 118.1億美元 |
支氣管炎是將空氣輸送到肺部的支氣管或空氣通道的發炎。它會導致咳嗽、氣喘和呼吸短促。由於呼吸道疾病的增加，全球支氣管炎治療市場可能會成長。全球污染水平上升、菸草消費量和生活習慣改變可能為市場成長提供機會。醫學進步也擴大了急性和慢性支氣管炎患者的治療選擇。
市場動態：
全球支氣管炎治療市場的成長是由污染水平上升、人口老化和菸草消費量增加等因素所推動的。碳排放的增加導致空氣品質惡化，空氣中粒狀物增加，導致呼吸道感染疾病上升。此外，隨著時間的推移，香菸和其他菸草製品會損害肺組織，使您更容易患支氣管炎。然而，有關菸草產品的嚴格法規和健康意識的提高可能會阻礙市場成長。數位健康工具和遠端監控設備的採用可以為遠端醫療服務提供機會，以更有效地管理支氣管炎護理。
本研究的主要特點
本報告對全球支氣管炎治療市場進行了詳細分析，包括以 2023 年為基準年的預測期（2024-2031 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、績效和策略等參數，包括全球支氣管炎治療市場的主要企業概況。
研究涵蓋的主要企業包括輝瑞、葛蘭素史克、賽諾菲安萬特、勃林格殷格翰、安斯泰來製藥、拜耳等。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球支氣管炎治療市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球支氣管炎治療市場的各種策略矩陣，將促進相關人員的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章 市場動態、法規與趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 機會
- 影響分析
- 市場趨勢
- 主要進展
- 監管場景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
第4章全球支氣管炎治療市場－COVID-19 的影響
- 整體影響
- 政府舉措
- COVID-19 對市場的影響
第5章全球支氣管炎治療市場，按類型，2019-2031（十億美元）
- 急性支氣管炎
- 慢性支氣管炎
第6章 全球支氣管炎治療市場，依治療方法，2019-2031（十億美元）
- 毒品
- 氧氣療法
第7章 全球支氣管炎治療市場，依藥物類別，2019-2031（十億美元）
- 發炎藥
- 抗生素
- 支氣管擴張劑
- 溶血劑
第 8 章 全球支氣管炎治療市場，依給藥途徑，2019-2031 年（十億美元）
- 口服
- 胃腸外的
- 吸入器/滴鼻劑
- 其他
第9章全球支氣管炎治療市場，按分銷管道，2019-2031（十億美元）
- 網路藥房
- 零售藥房
- 醫院藥房
第10章全球支氣管炎治療市場，按地區，2019-2031（十億美元）
- 拉丁美洲
- 歐洲
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中部非洲
- 南非
第11章競爭格局
- 公司簡介
- GlaxoSmithKline
- AstraZeneca
- Boehringer Ingelheim
- Novartis
- Merck &Co.
- Pfizer
- Teva Pharmaceutical Industries
- Sanofi
- Roche
- Johnson &Johnson
- Mylan NV
- Gilead Sciences
- AbbVie
- Bausch Health Companies
- Hikma Pharmaceuticals
- Amgen
- Sumitomo Dainippon Pharma
- Eli Lilly and Company
第12章分析師建議
- 命運之輪
- 分析師觀點
- 一致的機會圖
第13章參考文獻與調查方法
- 參考
- 調查方法
Global bronchitis treatment market is estimated to be valued at USD 8.22 Bn in 2024 and is expected to reach USD 11.81 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.3% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 8.22 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 5.30% | 2031 Value Projection: | US$ 11.81 Bn |
Bronchitis is an inflammation of the bronchi or air passages that carry air to the lungs. It causes coughing, wheezing and shortness of breath. Global bronchitis treatment market can witness growth due to rising rates of respiratory illnesses. Increasing pollution levels, tobacco consumption and changing lifestyle habits across the world can offer market growth opportunities. Advancements in medicine have also expanded treatment options available to patients suffering from both acute and chronic bronchitis.
Market Dynamics:
Global bronchitis treatment market growth is driven by factors such as rising pollution levels, aging population and growing tobacco consumption. Increased carbon emissions have deteriorated air quality and more particulate matter in the air leads to higher incidences of respiratory infections. Furthermore, cigarettes and other tobacco products damage lung tissues over time and make people more susceptible to bronchitis. However, stringent regulations around tobacco products and higher health awareness can hamper the market growth. Adoption of digital health tools and remote monitoring devices can offer opportunity for telehealth services to manage bronchitis care more efficiently.
Key Features of the Study:
This report provides in-depth analysis of the global bronchitis treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global bronchitis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer, GlaxoSmithKline, Sanofi Aventis, Boehringer Ingelheim, Astellas Pharma and Bayer
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global bronchitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bronchitis treatment market
Detailed Segmentation-
- By Type:
- Acute Bronchitis
- Chronic Bronchitis
- By Treatment
- Drugs
- Oxygen Therapy
- By Drug Class
- Anti-Inflammatory Drugs
- Antibiotics
- Bronchodilators
- Mucolytic
- By Route of Administration
- Oral
- Parenteral
- Inhalers/Nasal sprays
- Others
- By Distribution Channel
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- GlaxoSmithKline
- AstraZeneca
- Boehringer Ingelheim
- Novartis
- Merck & Co.
- Pfizer
- Teva Pharmaceutical Industries
- Sanofi
- Roche
- Johnson & Johnson
- Mylan N.V.
- Gilead Sciences
- AbbVie
- Bausch Health Companies
- Hikma Pharmaceuticals
- Amgen
- Sumitomo Dainippon Pharma
- Eli Lilly and Company
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Treatment
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Bronchitis Treatment Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Bronchitis Treatment Market, By Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Acute Bronchitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Chronic Bronchitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Bronchitis Treatment Market, By Treatment, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Oxygen Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Bronchitis Treatment Market, By Drug Class, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Anti-Inflammatory Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Bronchodilators
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mucolytic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Bronchitis Treatment Market, By Route of Administration, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Inhalers/Nasal sprays
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Bronchitis Treatment Market, By Distribution Channel, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
10. Global Bronchitis Treatment Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
11. Competitive Landscape
- Company Profiles
- GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Boehringer Ingelheim
- Novartis
- Merck & Co.
- Pfizer
- Teva Pharmaceutical Industries
- Sanofi
- Roche
- Johnson & Johnson
- Mylan N.V.
- Gilead Sciences
- AbbVie
- Bausch Health Companies
- Hikma Pharmaceuticals
- Amgen
- Sumitomo Dainippon Pharma
- Eli Lilly and Company
- GlaxoSmithKline
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
